A new hope in the treatment of steroid-refractory graft versus host disease (Sr-GVHD) after allogeneic hematopoetic stem cell transplantation (AHSCT): Ruxolitinib

dc.authorid0000-0003-1237-8281
dc.contributor.authorİlhan, Osman
dc.contributor.authorCengiz Seval, Güldane
dc.contributor.authorCivriz Bozdağ, Sinem
dc.contributor.authorDeveci, Burak
dc.contributor.authorPehlivan, Mustafa
dc.contributor.authorKaynar, Leylagül
dc.contributor.authorYavaşoğlu, İrfan
dc.contributor.authorBeköz, Hüseyin Saffet
dc.contributor.authorYönal Hindilerden, İpek
dc.contributor.authorYeğin, Zeynep Arzu
dc.contributor.authorDağdaş, Simten
dc.contributor.authorAvşar, Ayşe
dc.contributor.authorÖzkan, Atilla Hasan
dc.contributor.authorFırat Tuğlular, Tülin
dc.contributor.authorGöker, Hakan
dc.contributor.authorGülbaş, Zafer
dc.date.accessioned2021-01-21T08:06:27Z
dc.date.available2021-01-21T08:06:27Z
dc.date.issued2020
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstract[Abstract Not Available]
dc.identifier.citationİlhan, O., Cengiz Seval, G., Civriz Bozdağ, S., Deveci, B., Pehlivan, M., Kaynar, L. ... Gülbaş, Z. (2020). A new hope in the treatment of steroid-refractory graft versus host disease (Sr-GVHD) after allogeneic hematopoetic stem cell transplantation (AHSCT): Ruxolitinib. Bone Marrow Transplantation içinde (329-330. ss.).
dc.identifier.endpage330
dc.identifier.issn0268-3369
dc.identifier.issn1476-5365
dc.identifier.issueSUPPL 1
dc.identifier.startpage329
dc.identifier.urihttps://hdl.handle.net/20.500.12511/6332
dc.identifier.volume55
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherSpringer Nature
dc.relation.ispartofBone Marrow Transplantationen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectStem Cell Transplantation
dc.subjectAllogeneic Hematopoetic
dc.subjectGraft Versus Host Disease
dc.titleA new hope in the treatment of steroid-refractory graft versus host disease (Sr-GVHD) after allogeneic hematopoetic stem cell transplantation (AHSCT): Ruxolitinib
dc.typeConference Object

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: